Several subsequent studies evaluated the IHC expression of c-KIT in thymic neoplasms, revealing positivity in 4% of thymomas and 80–86% of thymic carcinoma cases [64,65,66,67]. This evidence concerns the gene KIT and thymic carcinoma.